CannTrust Holdings Inc (NYSE:CTST) has been assigned an average broker rating score of 1.60 (Buy) from the five brokers that provide coverage for the company, Zacks Investment Research reports. One equities research analyst has rated the stock with a hold recommendation, one has assigned a buy recommendation and three have given a strong buy recommendation to the company. CannTrust’s rating score has declined by 6.7% from three months ago as a result of various analysts’ upgrades and downgrades.
Brokers have set a 12 month consensus price target of $10.03 for the company and are predicting that the company will post ($0.05) earnings per share for the current quarter, according to Zacks. Zacks has also assigned CannTrust an industry rank of 82 out of 256 based on the ratings given to its competitors.
CTST has been the subject of several analyst reports. Bloom Burton reaffirmed an “accumulate” rating on shares of CannTrust in a report on Friday, March 29th. Zacks Investment Research raised CannTrust from a “hold” rating to a “buy” rating and set a $9.00 price objective for the company in a report on Tuesday, April 2nd.
Shares of NYSE CTST traded up C$0.40 during mid-day trading on Friday, reaching C$6.00. 4,227,784 shares of the company’s stock were exchanged, compared to its average volume of 3,674,029. The company has a debt-to-equity ratio of 0.06, a current ratio of 7.65 and a quick ratio of 5.54. The firm has a market cap of $633.84 million, a P/E ratio of -54.55 and a beta of 4.05. CannTrust has a twelve month low of C$4.35 and a twelve month high of C$11.97.
CannTrust (NYSE:CTST) last announced its quarterly earnings data on Thursday, March 28th. The company reported C($0.20) earnings per share for the quarter, missing the Thomson Reuters’ consensus estimate of C($0.04) by C($0.16). The company had revenue of C$16.20 million during the quarter, compared to analyst estimates of C$20.99 million. CannTrust had a negative net margin of 28.09% and a negative return on equity of 7.34%. The firm’s revenue was up 131.4% on a year-over-year basis. Equities analysts anticipate that CannTrust will post -0.01 EPS for the current year.
CannTrust Company Profile
CannTrust Holdings Inc produces and sells medical and recreational cannabis in Canada. It sells dried cannabis and cannabis extracts to the medical patients. CannTrust Holdings Inc was incorporated in 2015 and is headquartered in Vaughan, Canada.
Featured Article: How to track put option volume
For more information about research offerings from Zacks Investment Research, visit Zacks.com
Receive News & Ratings for CannTrust Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for CannTrust and related companies with MarketBeat.com's FREE daily email newsletter.